NCT02989012

Phase IIaTrials of GanMaoKangNing Granules

• Status: Unknown
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 96 (estimated)
• Sponsor: Dalian Zhen-Ao Bio-Tech Co., Ltd. · Industry
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

Randomized, double-blind, double- simulation, positive drug-and-Placebo-Controlled, multicenter, phase IIa clinical trials Study about GanMaoKangNing Granules in improving the symptoms of influenza.

Conditions

• Epidemic Influenza

Interventions

Type	Name	Description
DRUG	GanMaoKangNing Granules	3 times a day, 2 bags each time.
DRUG	Analogous Oseltamivir Phosphate Capsules	2 times a day,1 capsule each time.
DRUG	Oseltamivir Phosphate Capsules	2 times a day,1 capsule each time.
DRUG	Analogous GanMaoKangNing Granules	3 times a day, 2 bags each time.

Timeline

• Primary completion: 2019-07-01
• First posted: 2016-12-12
• Last updated: 2016-12-12

Locations

1 site across 1 country: China